The Transcription Factor SCX is a Potential Serum Biomarker of Fibrotic Diseases

Autor: Diego F. Hernández-Ramírez, Criselda Mendoza-Milla, Fernando Hernández-Sánchez, Alexia Esquinca-González, Sergio A. Benavides-Suárez, Carlos A. Núñez-Álvarez, Ivette Buendía-Roldán, Ana Lilia Torres-Machorro, Miguel Ramírez-Aragón, Tatiana S. Rodriguez-Reyna, Gael Güitrón-Castillo

Publikováno v: International Journal of Molecular Sciences
Volume 21
Issue 14
International Journal of Molecular Sciences, Vol 21, Iss 5012, p 5012 (2020)

Fibrosing diseases are causes of morbidity and mortality around the world, and they are characterized by excessive extracellular matrix (ECM) accumulation. The bHLH transcription factor scleraxis (SCX) regulates the synthesis of ECM proteins in heart

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f6a724b53004d505e296482d00615ce